The Wiskott-Aldrich syndrome (WAS) is an X-linked disorder of short-limbed dwarfism which occurs in increased frequency in characterized by eczema, decreased T lymphocyte function, and the Amish. In previous studies of Amish CHH patients we found decreased platelet count with small poorly functioning platelets.
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markedly decreased lymphocyte proliferative responses to phytohem-A unitarian hypothesis to explain the various immune and hematoagglutinin, concanavalin A (Con A), pokeweed mitogen and allogenlogical manifestations of WAS has not existed. The size of WAS eic cells. The present study was undertaken to determine if platelets normalized and their in vitro function improves these abnormalities were due to imbalances in lymphocyte subpopuing splenectomy suggesting the W~m e l e t defect is an acquired lations or defective lymphocyte activation. Studies on 9 CHH rather than an intrinsic defect. TO determine if the basic defect patients with specific monoclonal antibodies revealed a decrease in WAS patients is a membrane defect present in both platelets in the absolute number of T-and B-lymphocytes but a normal helpand lymphocytes, the size of lymphocytes of a WAS patient was er to suppressor cell ratio (OKT4+/ OKT8+). The number of monodetermined before and after splenectomy. The volume of the pacytes assayed by non-specific esterase, latex ingestion and antitient's lym hocytes was markedly reduced before splenectomy OKMl were normal; CHH monocytes functioned normally as helper No change in the normal blastogenic response of These data suggest that CHH lymphocytes have a defect in actithe patient's T lymphocytes was seen after splenectomy. These vation at a post-membrane, post-calcium influx step. CHH lymphoresults suggest that the basic defect in WAS may be a membrane cytes may be a useful model for the study of defects in cell prodefect which leads to the production of small platelets and liferation which may also exist in other cells of CHH patients lymphocytes (microplatel ets and microlymphocytes) by the spleen.
(e.g. chondrocytes).
STUDIES OF PRE-B CELLS IN HUMAN BONE MARROW.
? . Evidence was sought for the transfer of influenza specific Anti-PRP antibody (ab) in sera and mucosal secretions from 5 non-humoral immunity from mother to infant mouse. We studied children (>I8 mo of age) and 4 adults was quantified by radioaninfant mice born to 3 groups of mothers: (I) influenza immune tigen binding, before and 3 weeks after immunization with 15 vg mothers in whom influenza-specific serum antibody was suppressed of 'PRP. Total IgA in secretions was quantified by laser-nepheby passive antibody received prior to non-lethal influenza infeclometry. 8 of 9 subjects had detectable serum ab prior to vaction (I-~b), (2) influenza immune mothers with antibody (l+Ab) cination and all produced an increase (children 4.5-640X, adults and (3) non-immune controls.
CAPSULAR POLYSACCHARIDE (PRP)
3.3-48X) in serum ab following immunization. Prior to vaccina-I-Ab and control mothers as well as their infants showed no tion 3 of 5 children had detectable ab in nasal secretions evidence of influenza specific serum antibody 7 days after infec-(519-1828 ng ab/mg IgA). 2 of the 3 children with preimmunization tion. In contrast, high levels of serum antibody were found in nasal ab had an increase of ab following vaccination (2.3 & 7.7X) a1 l I+Ab mothers and infants 7 days after infect ion (~<0.001).
and 1 had no response. Both children with nondetectable preAfter a lethal influenza challenge, no infant mortality was found immunization nasal ab levels had detectable levels following in either immune group (I-Ab, I+Ab), whereas 1 1 of 16 infants in vaccination (1026 & 2093 ng ab/mg IgA). All adults had ab in the control group died. Three days after lethal challenge, I-Ab nasal mucus (120-1917 ng ab/mg IgA) and 3 of 4 adults had ab in infants showed a lower but not statistically different mean lung saliva (127-241 ng ablmg I g~) prior to vaccination.
3 of virus titer when compared to controls (P=0.11). At 7 days, lung 4 adults had an increase (1.6-6.2X) and 1 had a transient devirus titers of control infants continued to rise, while titers crease of nasal ab and all adults had an increase in salivary ab of I-Ab and I+Ab infants declined. Nasal virus titers of I-Ab (3-8.5X in those with detectable preimmunization levels and to and control infants did not differ, whereas, nasal virus titers 1419 ng ab/mg IgA in the other subject) following vaccination.
of I+Ab infants showed a decline from day 3 through 7 after
The subjects who did not have an increase in mucosal ab had the infection. We conclude that influenza specific non-serum-antibody medihighest preimmunization mucosal ab titers. We conclude that, ated immunity is I) transferred from mother to infant, 2) prounlike vaccination with many other non-rep1 icating antigens, tects against death, 3) plays a role in reducing lung virus shed-PRP immunization often increases mucosal as well as serum ab.
ding and 4 ) has no effect on nasal virus shedding.
